Hironobu Minami

发表

Effect of tumor burden and growth rate on treatment outcomes of nivolumab in head and neck cancer

K. Nibu, N. Kiyota, N. Otsuki, 2020, International Journal of Clinical Oncology.

A randomised, placebo-controlled, double-blind study of aprepitant in nondrinking women younger than 70 years receiving moderately emetogenic chemotherapy

S. Morita, M. Tanioka, S. Negoro, 2013, British Journal of Cancer.

Clinical effect of irinotecan in advanced and metastatic breast cancer patients previously treated with doxorubicin- and docetaxel-containing regimens.

K. Ishizawa, K. Itoh, Y. Sasaki, 2001, Japanese journal of clinical oncology.

Phase III trial of doxorubicin plus cyclophosphamide (AC), docetaxel, and alternating AC and docetaxel as front-line chemotherapy for metastatic breast cancer: Japan Clinical Oncology Group trial (JCOG9802).

T. Tabei, S. Takashima, N. Masuda, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.